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Failure of apoptosis has been postulated to cause the hypercellularity and thus excess scar-tissue formation of
hypertrophic scars (HTS). Here, we have examined the susceptibility of ﬁbroblasts derived from normal or HTS to
apoptosis induced during collagen-gel contraction, a wound-healing model. Normal scar (NS) ﬁbroblasts under-
went significant apoptosis (440% total) in contractile collagen, whereas apoptosis was not detected in HTS cells.
This inability was specific to apoptosis induced by contractile collagen because apoptosis could be induced using
diverse modalities. Since chronic ﬁbrotic tissue is known to be excessively cross-linked, we next examined
whether collagen matrix that had been conditioned by HTS ﬁbroblasts became refractory to enzymatic breakdown
and indeed, found that it is resistant to breakdown by both collagenase D and matrix metalloproteinase-2. Newly
formed extracellular matrix is stabilized by the enzyme, tissue transglutaminase, which we demonstrated to be
overexpressed by HTS ﬁbroblasts in vivo and in vitro. Reducing tissue transglutaminase activity in collagen gels
containing HTS ﬁbroblasts permitted induction of apoptosis on gel contraction, whereas increasing enzymic ac-
tivity in NS cell-containing gels completely abrogated collagen-contraction-induced-apoptosis. Together, these
observations show that HTS ﬁbroblasts exhibit resistance to a specific form of apoptosis elicited by contraction of
collagen gels, and that this phenomenon is dependent on excess activity of cell surface tissue transglutaminase.
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Hypertrophic scars (HTS) are severe excessive scars that are
characterized histologically by an abundance of collagenous
scar tissue and hypercellularity (mainly activated fibroblasts
known as myofibroblasts), although their exact etiology re-
mains unclear. During normal wound healing, the end of the
fibroproliferative phase is heralded by the disappearance of
myofibroblasts via apoptosis (Desmouliere et al, 1995). In
pathological scars, these cells persist, sometimes for many
years, which feasibly explains the excessive production of
scar tissue that is the prime feature of these scars.
Failure of apoptosis in HTS has long been hypothesized
but evidence is controversial and often contradictory. The
bcl-2 proto-oncogene, whose protein product protects cells
from apoptosis, has been demonstrated to be strongly ex-
pressed in vivo by fibroblasts within HTS and keloid tissue
(Teofoli et al, 1999; Moulin et al, 2004), whereas the death
receptor ligand, fas, has been shown to be decreased in
HTS tissue and derived fibroblast cultures (Wassermann
et al, 1998). In addition, Chodon et al (2000) reported that
although keloid-derived fibroblasts were refractory to Fas-
mediated and staurosporine-induced apoptosis, HTS cells
were not. Furthermore, it has been reported that expression
of caspase-3 is higher in hypertrophic and keloids scar tis-
sue than in comparable age flat normal scars (NS), sug-
gestive of increased levels of apoptosis in the pathological
tissue (Akasaka et al, 2000). Indeed, this group went on to
demonstrate significantly higher levels of apoptosis in HTS
tissue compared with that of normal (flat) scars (Akasaka
et al, 2001). This discrepancy between different sources of
evidence is undoubtedly because of differences in exper-
imental procedures, such as the maturity of the scar tissue
used, whether tissue or cultured cells were examined, and
the methods utilized to induce apoptosis, some of which
bear no relation to the physiological processes going on
within the maturing wound.
The exact triggers of apoptosis during wound healing
remain unknown, although recent work has indicated a po-
tential role for contractile fibrillar collagen (Fluck et al, 1998;
Grinnell et al, 1999). Here, dermal fibroblasts seeded into
contracting but not anchored collagen gels nor contracting
fibrin gels were seen to undergo apoptosis. Nevertheless,
the exact triggers of apoptosis under these experimental
circumstances are also undefined. The major differences
between the two gel types (anchored vs contractile) are
Abbreviations: CrIA, collagen contraction/remodelling-induced
apoptosis; 14-DAB,1,4-diaminobutane; 3D, three-dimensional;
ECM, extracellular matrix; FCS, fetal calf serum; HTS, hypertro-
phic scar; MMP, matrix metalloproteinase; NS, normal scar; PBS,
phosphate-buffered saline; RT, room temperature; SDS-PAGE, so-
dium dodecylsulfate-polyacrylamide gel electrophoresis, tTgase,
tissue transglutaminase
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regarding mechanical loading (tension), cell cycle status (con-
tinued cycling vs cycle arrest (Nakagawa et al, 1989a, b; Ni-
shiyama et al, 1989; Kono et al, 1990)), and also their apparent
ability to remodel extracellular matrix (ECM) proteins, with
anchored gels being reported to exhibit continued collagen
synthesis, whereas this is reduced in contractile gels together
with a concomitant increase in matrix metalloproteinase
(MMP) activity (higher MMP expression and lower tissue in-
hibitor of metalloproteinase expression) (Nusgens et al, 1984;
Unemori and Werb, 1986; Paye et al, 1987; Fukamizu and
Grinnell, 1990). This latter observation is particularly intriguing
given the recent findings of Buckley et al (1999), who deter-
mined that small soluble peptides containing the RGD (argine,
glucine, aspartic acid) amino acid motif (and therefore poten-
tial breakdown products of collagen/ECM remodelling) can
induce apoptosis of fibroblasts via integrin-independent in-
ternalization and direct activation of pro-caspase 3.
We therefore examined whether HTS cells would be
susceptible to a contractile collagen-induced, and poten-
tially wound healing-related, form of apoptosis. We further
investigated whether the differences in apoptosis ability
under these specific circumstances were related to chang-
es in biochemical modification of collagen, since chronic
fibrosis is linked with overmodification of the ECM in both
the liver and skin (Ricard-Blum et al, 1993, 1996, 1998; Hi-
rota et al, 2003) and an increased isopeptide cross-linking
of ECM has been reported in HTS tissue (Dolynchuk, 1996).
Overmodification of ECM proteins can dramatically alter the
behavior of cells inhabiting the matrix through changes in
mechanical properties, changes in the availability of a va-
riety of biologically active substances by binding to the
ECM or the availability of specific binding motifs within the
matrix molecules themselves, and finally altering the break-
down and remodelling of the matrix. This study then went
on to determine the role of the enzyme, tissue transgluta-
minase, which is thought to be responsible for the stab-
ilization of ECM (Ricard-Blum et al, 1996; Grenard et al,
2001). Overexpression of this enzyme has been found in
many fibrotic conditions, liver fibrosis (Grenard et al, 2001),
Dupuytrens disease (Dolynchuk and Pettigrew, 1991), and
hypertrophic scarring, along with overexpression of one of
its major ligand groups, the collagen III-related peptides
(Bowness et al, 1987a, b).
We report that whereas NS fibroblasts simulate dermal
fibroblasts in their ability to undergo collagen contraction-
induced apoptosis, HTS cells appear refractive to this spe-
cific form of apoptosis. Further, the ability of cells to under-
go this form of apoptosis is linked with changes in the
biochemical modification of collagen (resulting in altered
enzymatic breakdown products) and the activity of cell sur-
face tissue transglutaminase (tTgase). These results sug-
gest an integral role for tTgase in the pathogenesis of
hypertrophic scarring and also indicate a potential mech-
anism by which inhibitors of tissue transglutaminase might
be effective as anti-scarring therapeutic agents.
Results
HTS ﬁbroblasts fail to undergo apoptosis in response
to collagen contraction/remodelling cues In 1998, Fluck
et al published the finding that fibroblasts derived from nor-
mal skin dermis, when seeded into three-dimensional- (3D-)
collagen gels and allowed to contract and therefore remodel
those gels, were induced to undergo apoptosis. We therefore
determined whether fibroblasts derived from different scar
types would be equally susceptible to such a phenomenon.
Since the degree to which the cells proliferate in collagen
gels differs between anchored and contractile gels, we tit-
rated the amount of serum used to supplement the medium
down to that which kept the cells quiescent but healthy
(1%—not shown). All further experimentation was performed
in this minimal growth medium in order to ensure that any
differences seen in cell number were as a result of cell death
and not different proliferation rates. NS cells seeded into
collagen gels in minimal medium, when allowed to contract
the gels, underwent significant cell death (  35%–45% de-
pending on cell strain, po0.001), reaching a maximum at
approximately 3–4 d (Fig 1A). This drop in viable cell number
was not seen in gels that remained anchored. In contrast,
cells derived from HTS failed to undergo cell death under
either circumstance. The results shown are representative of
those obtained for all NS (n¼ 8) and HTS (n¼6) fibroblast
strains tested. The typical appearance of cells within the gels
after 4 d is shown in Fig 1B–E: both NS cells (B) and HTS
cells (D) in anchored collagen gels are seen to be distributed
randomly, being mainly bipolar but with occasional poly-
dendritic cells present. A large proportion of the NS cells in
contractile collagen gels (C) are rounded up (black arrows),
exhibiting dense compacted chromatin typical of that seen in
apoptotic cells; the remaining cells appear multistellate and
occasionally bipolar. In contrast, very few HTS cells in con-
tractile collagen gels were rounded up (E—black arrow), be-
ing mainly multistellate in appearance (white arrow), with the
extensive network of dendrite-like structures often extending
outside the plane of focus. A terminal deoxynucleotidyl
transferase-mediated dUTP nick end-labelling technique
confirmed that the cell death seen was as a result of
apoptosis. A typical example of this is shown in Fig 2: (A)
demonstrating end-labelled nuclei of NS fibroblasts harvest-
ed from a 4-d-old contractile gel, whereas (B) shows the
unlabelled nuclei typical of HTS cells harvested from a 4-d-
old contractile gel. Interestingly, the ability of either cell type
to contract collagen gels appears equivalent, with both NS
and HTS cells contracting the gels by approximately 55% of
the original gel area by 4 d (Fig 3).
Apoptosis defect specific to that induced by collagen-
gel contraction To determine whether this inability of HTS
cells to undergo apoptosis is a general phenomenon or
specific to this particular induction signal, we examined
whether HTS cells were sensitive to a variety of different
methods of inducing apoptosis, including ethanol, do-
xorubicin, and camptothecin. The mean cell death for
n¼3 different cell strains of each scar-tissue type are plot-
ted in Fig 4D (ethanol) and 4E (doxorubicin). HTS fibroblasts
demonstrated response curves identical (p values46) to NS
cells irrespective of the apoptotic stimuli tested. Cells treat-
ed with 10% ethanol in serum-free medium (SFM) show
considerable rounding up and death (Fig 4B), which steadily
increased over time until few cells remained alive after 8 h.
Treatment with 1 mg per mL of either doxorubicin (Fig 4C) or
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camptothecin (not shown) in normal growth medium (con-
taining 10% serum) resulted in cell death that steadily in-
creased over time, reaching a maximum at 24 h (Fig 4E). In
all cases, cell death was attributed to apoptosis by nick
end-labelling (not shown).
Gels inhabited by HTS cells are harder to break down
compared with gels inhabited by NS cells Under the
quiescent conditions in which we performed our collagen-
contraction experiments, the major differences between
anchored versus contractile collagen gels that might influ-
ence the induction of apoptosis are either mechanical (al-
tering cellular stress/tension) or related to collagen
breakdown/synthesis. Either of these putative mechanisms
could be affected by changes in the post-translational
modification of newly laid down collagen, and there is in-
creasing evidence of biochemical overmodification of ECM
in conditions linked with fibrosis. We therefore examined
whether cells derived from the different scars differed in
their ability to modify the collagen gel.
Changes in modification of the collagen by the two cell
types were initially examined using collagenase D digestion.
Sodium dodecylsulfate-polyacrylamide gel electrophore-
sis (SDS-PAGE) analysis of digestion products showed
little significant difference in protein bands over 50 kD in
size. Typically, the majority of differences were seen in
breakdown products of less than 50 kD (Fig 5). In gels
conditioned for 3-d the only obvious difference is that the
NS cell-gel product of approximately 10 kD (arrow, lane 1) is
absent in the HTS cell-gel products (lane 2). After 7 d, the
differences become more marked, with many bands either
not present, reduced in density, or appearing to exhibit an
altered mobility in HTS cell gels (arrows, lane 3 vs lane 4). A
plot of the 7-d samples clearly shows the disappearance or
reduction of bands at approximately 48, 39, 35, 33, 21, 20,
19, and 10 kD. These results appear to suggest modificat-
Figure 1
Collagen contraction/remodelling-induced cell death. Fibroblasts
derived from either normal scars (NS) or hypertrophic scars (HTS) were
seeded into collagen gels and incubated for 3 d, after which time they
were either maintained anchored or released and allowed to contract
the gel for a 4-d period. At daily time points, the cells were harvested
and the number of apoptotic cells was assessed through viable staining
and nick end-labelling of apoptotic nuclei. Typical results are presented
in (A), which shows a graph of the percentage of cells undergoing
apoptosis versus time: NS cells in anchored gels (open circles), NS cells
in contractile gels (closed circles), HTS cells in anchored gels (open
triangles), and HTS cells in contractile gels (closed triangles). Each point
represents the mean of triplicate gels, with the error bars being the
standard deviation from the mean. Micrographs B–E illustrate the typ-
ical cellular morphology seen in each type of gel (formal saline fixed and
hematoxylin stained): (B) NS, anchored; (C) NS, contractile; (D) HTS,
anchored; (E) HTS, contractile. Black arrows indicate rounded-up dying
cells and the white arrow indicates live fibroblasts within the HTS cell-
containing contractile gel. Scale bar¼50 mm.
Figure2
Confirmation of apoptosis. Typical terminal deoxynucleotidyl transf-
erase end-labelling of apoptotic nuclei (green fluorescence) with red
(propidium iodide) counterstaining of cells harvested from collagen gels
that had been allowed to contract for 4 d: normal scar cells (A) or
hypertrophic scar cells (B). Scale bar¼25 mm.
Figure3
Degree of collagen contraction. Typical examples of collagen gels
that had been allowed to contract for 4 d that contained either normal
scar (NS) (A) or hypertrophic scar (HTS) (B) cells. (C) shows the mean
percentage contraction of triplicate gels calculated as the mean per-
cent reduction in diameter of the gels from the original (measured as an
average of five random diameters of each gel) and the results of a
standard Student’s t test.
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ion of the collagen gel by HTS cells in such a way as to
dramatically change the products of collagenase digestion.
We therefore went on to examine the susceptibility of
such gels to MMP-2, an enzyme responsible for the pro-
duction of smaller breakdown products during collagen re-
modelling and active during cutaneous wound healing. The
proteolytic products of MMP-2-digested cell-conditioned
collagen were then analyzed via SDS-PAGE. The typical
appearances of the different collagen chains are seen in
undigested acid-soluble collagen samples from both NS
and HTS cell-conditioned gels (Fig 6A, lanes 1 and 2, re-
spectively); a1 (  130 kD), a2 (  120 kD), and b (270—300
kD), with the g chains being just discernible at the top of the
gel. For the MMP-2-digested collagen samples, both the a
and b chains of the NS cell-conditioned gel have been
completely digested, whereas the a chain band (  130 kD)
of HTS cell-conditioned collagen is still quite obvious (Fig
6B, lanes 1 and 2). The digested NS sample does show a
strong band of higher mobility at approximately 100 kD that
may represent a breakdown product of the collagen diges-
tion. Both gel types exhibited large amounts of breakdown
products of less than 37 kD, but their banding patterns were
too indistinct to determine any reproducible differences be-
tween the two gels (not shown).
Tissue transglutaminase is overexpressed by HTS cells
in vivo and in 3D-collagen gels but not in monolayer
culture One of the enzymes known to be responsible for
biochemical cross-linking and thus stabilization of ECM is
tissue transglutaminase. Immunohistochemical staining of
tissue samples taken from the scars from which the cell
cultures were derived corroborated the previous report (Do-
lynchuk, 1996) that mature HTS exhibit high expression of
tissue transglutaminase on fibroblastic cells within the scar
matrix, whereas NS of a similar age do not (Fig 7A, B). To
determine whether if this was also the case in cultured HTS
cells, compared with NS cells immunohistochemical stain-
ing was attempted on monolayer cultures, but with little
success, with tissue transglutaminase being barely detect-
able in either type of scar fibroblasts cultured on plastic.
When these cells are cultured in 3D-collagen gels, however,
tTgase expression is detectible in both cell types (Fig 7C,
Figure 4
Chemically induced apoptosis. Micrographs illustrating hypertrophic
scar (HTS) cell death induced by standard inducers of cellular
apoptosis. (A) Appearance of cells in normal medium, (B) induction of
apoptosis after 7 h in 10% ethanol, and (C) apoptosis of cells after 24 h
treatment with 1 mg per mL doxorubicin. Scale bar¼ 100 mm. (D, E)
Graphical representation of cell death over time induced by 10% et-
hanol and 1 mg per mL doxorubicin, respectively. Data plotted are the
mean of n¼ 4 cell strains of either normal scar (NS) (circles) or HTS
(triangles), with error bars being the standard deviation from the mean.
Figure5
Collagenase D digestion of cell-conditioned collagen. Collagen gels
seeded with fibroblasts derived from either normal scar (NS) or hype-
rtrophic scar (HTS) were cultured for the whole time course of the
collagen contraction-induced apoptosis experiment (7 d). Gels were
harvested either at day 3 (the point at which the gels are normally freed
to allow contraction) or day 7 (i.e. 4 d after contraction began and the
point at which apoptosis is usually maximal). The gels were digested
using collagenase D and the digestion products were analyzed on 12%
sodium dodecylsulfate-polyacrylamide gel electrophoresis gel under
non-reducing conditions. (A) A typical gel: Lanes 1 (day 3 specimen)
and 3 (day 7) are NS cell-conditioned gels; lanes 2 (day 3) and 4 (day 7)
are HTS cell-conditioned gels. The arrows indicate bands that have
altered between NS and HTS lanes of the same time point. (B) A plot of
the density of lane 3 (dashed line) and 4 (solid line) versus molecular
weight. The arrows indicate major changes in banding patterns be-
tween the NS and HTS cell-conditioned gels.
APOPTOSIS FAILURE IN HYPERTROPHIC SCAR 75125 : 1 JULY 2005
D), with a particularly marked upregulation in cells derived
from HTS. This was confirmed using SDS-PAGE and west-
ern blotting (not shown).
Tissue tranglutaminase treatment of collagen inhabited
by NS cells mimics the pattern of collagenase break-
down products of HTS cell-conditioned collagen Colla-
gen gels seeded with NS cells and cultured anchored for 7 d
in the absence or presence of 0.0144 U per mL tissue trans-
glutaminase were subject to 40 min collagenase D digestion
and the breakdown products were analyzed. Similar to the
comparison of HTS- and NS cell-conditioned gels, there
was no discernible difference in digestion product bands
over 50 kD in size, with the majority of differences being
seen in breakdown products of less than 50 kD. A repre-
sentative example is shown in Fig 7E: Lane 1 is the un-
treated NS gel and lane 2 is the exogenous tTgase-treated
NS gel. The tTgase treatment produced a markedly different
banding pattern (the major differences are indicated with
arrows). This proteolytic profile appears similar to that seen
for HTS cell-conditioned gels (Fig 5). A plot of lane density
against molecular weight clearly shows the disappearance
or reduction of bands at approximately 44, 39, 36, 34, and a
triplet centering around 21 kD (Fig 7F). These results sug-
gest that addition of exogenous tTgase dramatically chang-
es the products of collagenase digestion in such a way as to
mimic that of collagen gels conditioned by HTS cells.
Inhibition of transglutaminase activity in HTS cells nor-
malizes their behavior in response to collagen contrac-
tion/remodelling The naturally occurring polyamine known
as putrescine, or 1,4-diaminobutane (1,4-DAB), is known to
inhibit the cross-linking activity of tissue transglutaminase in
vitro and in vivo. We therefore attempted to modulate the
overactivity of tTgase seen in HTS cells back toward more
normal levels using 1,4-DAB and to examine what effect this
had on the inability of these cells to undergo collagen-con-
traction/remodelling-induced apoptosis (CrIA). Initially, we
assayed the effect of a range of 1,4-DAB concentrations in
minimal growth medium on the proliferation of fibroblasts in
monolayer culture over a period of 10 d, in order to assess
whether 1,4-DAB had any mitogenic or toxic effects in the
absence of a 3D-collagenous environment. Typically, the
only difference was found at the highest concentration (500
mg per mL) where the cell number was significantly lower
(po0.01) than that of the media-only control (at day 10 on-
ly—Fig 8A). A 1,4-DAB concentration of 250 mg per mL was
therefore chosen for further experimentation.
Fibroblasts derived from HTS seeded into collagen gels
were incubated for 3 d either in the presence or absence of
250 mg per mL 1,4-DAB, after which time they were either
maintained anchored or allowed to contract the gel in these
media for a further 4-d period, whereupon cell death was
Figure 6
Matrix metalloproteinase-2 (MMP-2) digestion of cell-conditioned
collagen. Acid-soluble fractions of cell-conditioned collagen gels were
heat denatured, digested with MMP-2 for 24 h, and analyzed using
a standard non-reducing sodium dodecylsulfate-polyacrylamide gel
electrophoresis 7.5% gel. Collagen samples before digestion are
shown in A, lanes 1 and 2—normal scar (NS) and hypertrophic scar
(HTS) cell-conditioned collagen, respectively, showing collagen bands
a, b, and g chains. MMP-2-digested collagen samples are in (B) lanes 1
and 2—NS and HTS cell-conditioned collagen, respectively.
Figure7
Tissue transglutaminase expression and modification of collagen.
Immunohistochemical staining for tissue transglutaminase: (A) normal
scar (NS) tissue46 mo maturity—dotted arrow indicates staining in
blood vessel; solid arrow indicates staining in the basal layer of the
epidermis, (B) chronic hypertrophic scar (HTS) tissue (46 mo matu-
rity)—dotted arrow indicates staining in blood vessels; solid arrows
indicate staining of fibroblastic cells within the scar matrix, (C) NS cells
seeded into collagen gel and cultured for 7 d–arrow indicates weak
staining of occasional cells, with the vast majority of cells having un-
detectable staining, (D) HTS cells seeded into collagen gel and cultured
for 7 d—showing that the majority of cells exhibit strong staining for this
enzyme. Scale bar¼50 mm. (E) shows 12% sodium dodecylsulfate-
polyacrylamide gel electrophoresis gel analysis typical of collagenase-
D-digested (40 min) collagen gels, which had been seeded with NS
fibroblasts and cultured for 7 d in the absence (control) or presence of
0.0144 U per mL of tTgase: Lane 1 (untreated control) and 2 (tTgase-
treated). The arrows indicate the main bands that have altered between
untreated and tTgase-treated samples. (F) A plot of the density of lane 1
(dashed line) and 2 (solid line) versus molecular weight. The arrows
indicate major changes in banding patterns between the untreated and
tTgase-treated collagen gels.
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assessed. The experiments were repeated at least three
times with n¼3 cell lines. Typical results plotted in Fig 8B
show that addition of 1,4-DAB to the medium during the
course of the experiment had a profound effect on the abil-
ity of collagen contraction to induce apoptosis (po0.001) of
HTS cells, with the level of death (  47% Fig 8B) being
similar to that seen with NS cells (Fig 1A).
Treatment of collagen gels with exogenous transgluta-
minase inhibits apoptosis of NS cells in response to
collagen contraction/remodelling Polyamines are pleio-
tropic molecules that could potentially affect cell death in
many different ways other than solely through the inhibition
of the action of tTgase. We therefore used an alternative
approach and examined whether an increase in tTgase ac-
tivity in collagen gels inhabited by NS fibroblasts would en-
gender resistance to CrIA in these ‘‘normal’’ cells. Again, we
first determined whether tTgase had any effect (either mi-
togenic or toxic) on the cells in the absence of a 3D-col-
lagenous environment, by performing growth curves using
monolayer cultures of NS fibroblasts. The titration curve at
each time point is plotted in Fig 9A and shows that none of
the concentrations of tTgase used significantly affected the
growth or death of these cells. A tTgase concentration of
0.0144 U per mL was used in all further experimentation and
is of the same order of concentration as that used by Murthy
et al (1991) to cross-link fibrinogen.
Fibroblasts derived from NS seeded into collagen gels
were incubated for 3 d either in the presence or absence of
0.0144 U per mL tissue transglutaminase, after which time
they were either maintained anchored or allowed to contract
the gel in these media for a further 4-d period, after which
cell death was assessed. Experiments were repeated at
least three times with n¼3 cell lines. Typical results plotted
in Fig 9B show that, in contrast to the untreated gels
(po0.001), NS cells in contractile collagen gels in the pres-
ence of added exogenous tissue transglutaminase did not
undergo apoptosis (p40.8).
Discussion
Recently, a role for fibrillar collagen has been indicated in
the induction of apoptosis of fibroblasts (Fluck et al, 1998;
Grinnell et al, 1999), thus establishing an experimental stim-
ulus of apoptosis with relevance to the healing wound.
Figure 8
Inhibition of tissue transglutaminase activity in hypertrophic scar
(HTS) cell-containing collagen gels. The effects of 1,4-diaminobu-
tane (1,4-DAB) on the cell number of fibroblasts cultured in monolayer
in minimal growth medium were titrated over a 10-d period (A).  in-
dicates the concentration at which the cell number was significantly
(po0.01) lower than that of the media-only control (at day 10 only). HTS
fibroblasts seeded into collagen gels were incubated for 3 d either in
the presence or absence of 250 mg per mL 1,4-DAB, after which time,
they were either maintained anchored or allowed to contract the gel in
these media for a further 4-d period. At day 4 (post-release), the cells
were harvested from the gels using collagenase D and the number of
apoptotic cells was assessed through viable staining and nick end-
labelling of apoptotic nuclei. Typical results are presented in (B), which
shows a graph of the percentage of cells undergoing apoptosis: an-
chored gels (solid bars) and contractile gels (striped bars). Each point
represents the mean of triplicate gels, with the error bars being the
standard error of the mean (po0.001).
Figure9
Treatment of normal scar (NS) cell-containing collagen gels with
tissue transglutaminase. The effects of added exogenous tissue
transglutaminase on the cell number of fibroblasts cultured in mono-
layer in minimal growth medium were titrated over a 10-d period—no
significant difference was seen in the cell number over the whole tit-
ration range tested. NS fibroblasts seeded into collagen gels were in-
cubated for 3 d either in the presence or absence of 0.0144 U per mL
tissue transglutaminase, after which time, they were either maintained
anchored or allowed to contract the gel in these media for a further 4-d
period. At day 4 (post-release), the cells were harvested from the gels
using collagenase D and the number of apoptotic cells assessed
through viable staining and nick end-labelling of apoptotic nuclei. Typ-
ical results are presented in (B), which shows a graph of the percentage
of cells undergoing apoptosis: anchored gels (solid bars) and contrac-
tile gels (striped bars). Each point represents the mean of triplicate gels,
with the error bars being the standard error of the mean. (po0.001).
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Considering the long-hypothesized possibility that the
hypercellular nature (and potentially the whole pathology)
of hypertrophic scarring is caused by a failure of apoptosis,
we therefore investigated whether a reduced susceptibility
of fibroblasts to this particular form of apoptosis might un-
derlie the pathology of this condition.
We have demonstrated that cell lines derived from
chronic (46-mo old) HTS are resistant to this CrIA, where-
as fibroblasts derived from NS of similar maturity mimic
dermal fibroblasts and are susceptible to CrIA. These find-
ings highlight distinct patterns of cellular behavior exhibited
by these cells indicating intrinsic cellular differences rather
than purely environmental cues in the pathology of hype-
rtrophic scarring. Furthermore, we have shown that a gen-
eral defect in the machinery of apoptosis is not indicated,
but rather something more particular to the specific form of
apoptosis induction going on within a contractile 3D-colla-
gen structure. These findings are not only in accordance
with the hypothesis that the hypercellular characteristic of
hypertrophic scarring is because of a failure of cellular
apoptosis but also supports the proposition that collagen is
involved in the mechanism that switches off the fibropro-
liferative phase of wound healing.
We further postulated that this phenomenon of apoptotic
resistance might be caused by the matrix of HTS being
overmodified in some way, either via intracellular post-
translational modification that goes on during biosynthesis
or through extracellular biochemical modification, since
chronic fibrotic tissue (both skin and liver) is known to be
excessively cross-linked (Ricard-Blum et al, 1993, 1996,
1998; Dolynchuk, 1996; Hirota et al, 2003). Overmodifica-
tion of ECM would considerably change its biochemical
properties and how cells interact with it, potentially affecting
the mechanical properties of the matrix and thus the ten-
sional load put upon the inhabiting cells. Excessive cross-
linking of ECM might also result in hidden or uncovered
cellular binding sites within the matrix proteins themselves,
or make available or sequester growth factors or the like.
Furthermore, this type of modification would affect the
quality of enzymatic cleavage, potentially making the matrix
more refractive to enzymatic breakdown.
We demonstrated that HTS cells biochemically modify
collagen in such a way as to change the products of pro-
teolytic cleavage that result from digestion with a strong
collagenase (Collagenase D). In addition, HTS cell modifi-
cation of collagen causes resistance to enzymatic cleavage
by MMP-2, a collagenase highly active during cutaneous
wound healing. These results are analogous to recent find-
ings in a model of chronic dermatitis induced in rabbit ears
(Hirota et al, 2003) and are of particular interest considering
work by Buckley et al (1999), who implicated potential
breakdown products of the ECM in the initiation of
apoptosis in both lymphocytic cells and fibroblasts. Small
soluble peptides containing the RGD amino acid motif were
reported to directly induce apoptosis through an integrin-
independent mechanism by direct binding to and activation
of pro-caspase-3 as apposed to the alternative mechanism
of inducing apoptosis (termed anoikis) through blocking in-
tegrin-mediated cell-matrix contact (Frisch and Ruoslahti,
1997). It is possible that this overmodification and thus
stabilization of collagen by HTS cells might reduce the pro-
duction of small soluble RGD-containing peptides that oc-
curs on remodelling, thereby removing a potential trigger for
apoptosis.
The stabilization of newly formed ECM is thought to be
largely accomplished through the actions of tissue trans-
glutaminase (or transglutaminase II) (Ricard-Blum et al,
1996; Grenard et al, 2001). The activity of this enzyme is
markedly increased during wound healing, substantially
effecting both the breaking strength of wounds and the
solubility of ECM proteins (Bowness et al, 1987b, 1988;
Dolynchuk et al, 1994; Haroon et al, 1999). Tissue trans-
glutaminase cross-links proteins through the formation of
isopeptide bonds between reactive g-glutaminyl groups in
certain specific proteins and the e-amino group of lysine in
other proteins. Some of the components of early granulation
tissue, type III collagen along with its aminopropeptides,
have been shown to be particularly good substrates for
transglutaminase (Bowness et al, 1987a, b), and elevated
levels of these have been detected in both HTS (Weber et al,
1978) and related fibrotic conditions such as Dupuytrens
disease (Brickley-Parsons et al, 1981). Since the affected
fascia of Dupuytrens disease is also known to have in-
creased transglutaminase levels (Dolynchuk et al, 1991),
and increased extracellular activity of this enzyme has been
detected in chronic HTS tissue (Dolynchuk, 1996), it seems
feasible that the transglutaminase cross-linking of ECM
might be expected to be excessive in these conditions.
We have not only demonstrated high expression levels of
tissue transglutaminase in chronic HTS tissue, corroborat-
ing the previous report (Dolynchuk, 1996), but also in HTS
cells in vitro, but only when cultured within 3D-collagen gels
and not in monolayer culture. This apparent matrix depend-
ence of the expression, stabilization or extracellular local-
ization of tissue transglutaminase is in contrast to a recent
report comparing high tTgase-expressing pre-senescent,
senescent, and immortalized dermal fibroblasts, which re-
ported no dependence on culture environment (Stephens
et al, 2004), and thus requires further investigation. In sup-
port of the theory that the overexpression of cell surface
tTgase might explain the change in resistance to enzymatic
digestion, treatment of NS cell-seeded collagen gels with
exogenous tTgase was shown to alter the products of pro-
teolytic breakdown in such a way as to mimic that of HTS
cell-seeded gels. We went on to manipulate the activity of
tissue transglutaminase in cell-containing collagen gels and
found that inhibition of tTgase activity in collagen gels con-
taining HTS cells resulted in the normalization of their be-
havior; allowing induction of apoptosis on gel contraction,
whereas boosting tTgase activity in gels containing NS cells
completely abrogated CrIA. These findings establish a role
for tTgase in the protection from CrIA and suggest that the
prolonged overexpression of this enzyme by HTS fibro-
blasts may be the basis of their pathology.
A therapeutic use of 1,4-DAB as an inhibitor of trans-
glutaminase activity in HTS has been considered previously.
A phase II clinical study was set up in human patients with
HTS to primarily determine safety but also the efficacy of a
topical cream containing 0.8% wt/vol 1,4-DAB (Fibrostat
Procyon Biopharma, Inc., Dorval, Canada) (Dolynchuk et al,
1996). The trial was set up as a double-blind crossover
study over two successive 4-wk periods, which showed
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that Fibrostats treatment resulted in a significant improve-
ment in scar appearance irrespective of the order given.
Further work used HPLC analysis to quantitate the e (g-
glutamyl) lysine cross-linking of ECM proteins and found
that these were significantly reduced in Fibrostats-treated
HTS tissue compared with vehicle-only control-treated scar
(Dolynchuk, 1996), thus supporting a possible therapeutic
role for topical 1,4-DAB in the treatment of HTS. Our results
suggest that the mechanism of therapeutic action could be
via allowing the HTS fibroblasts to finally undergo apopto-
sis, thus reducing hypercellularity of the scars and speeding
their regression.
How tissue transglutaminase activity might contribute
toward the sensitivity of a cell to the specific form of
apoptosis induced by collagen contraction is a question
that still needs addressing. This enzyme is a highly multi-
functional molecule exhibiting a plethora of new and diverse
bioactivities, a comprehensive review of which, including
the cell structure-stabilizing role of intracellular transgluta-
minase during apoptosis, is given by Griffin et al (2002).
Indeed, tTgase is unique in that it has multiple enzymatic
functions. Apart from its cross-linking activity, it has long
been known that tTgase also directly binds guanosine
triphosphate (GTP)/guanosine diphosphate and undergoes
a GTPase cycle, thus allowing this enzyme to function di-
rectly in signal transduction (Nakaoka et al, 1994; Mian et al,
1995). In addition, tTgase has also recently been reported to
have intrinsic kinase activity, phosphorylating insulin-like
growth factor binding protein-3 (Mishra and Murphy, 2004).
Each of any of these three distinct enzymatic activities ex-
hibited by tTgase could affect apoptosis in multiple different
ways. Our findings that 1,4-DAB, which specifically inhibits
the cross-linking activity of extracellular tTgase, and added
exogenous tTgase both affect susceptibility to CrIA how-
ever, suggests that this phenomenon is strictly affected by
the cross-linking activity of extracellular (presumably cell
membrane-bound) tTgase and not through this enzyme’s
alternative functions within the cell. Interestingly, CrIA must
not therefore involve fibroblast spreading, motility, nor their
ability to form stress fibers or focal adhesions, since all of
these cellular functions have recently been found to be de-
pendent on the G-protein function of tTgase rather than its
cross-linking ability (Stephens et al, 2004). Our observation
of equivalent contraction by HTS and NS cell-inhabited
collagen gels would appear to suggest that contraction
is not affected by overactivity of tTgase and that CrIA does
not necessarily follow contraction. Whether contraction in
high tTgase activity gels differs in a wholly qualitative way
however is unknown.
Since cell surface transglutaminase is well known for its
stabilization of ECM and its ability to reduce the solubility or
degradability of these proteins, it thus has the potential to
reduce the production of small RGD-containing peptides
that might play a role in the induction of apoptosis as men-
tioned previously. Alternative roles for this particular
enzymatic function, however, are being uncovered, which
also have the potential to affect cell survival. Whether these
play a role during collagen contraction is currently under
investigation. Transglutaminase has been implicated in the
activation of transforming growth factor-b1 (TGF-b1) via
cross-linking of latent TGF-b-binding protein-1 (Nunes et al,
1997; Verderio et al, 1999). TGF-b-mediated apoptosis has
been implicated in the formation and homeostasis of many
different tissues including the immune system (particularly
B- and T-cell homeostasis), liver, prostate, uterus, breast,
nervous system (Schuster and Krieglstein, 2002). More re-
cently, the importance of TGF-b-induced apoptosis has
been demonstrated during tissue formation and remodelling
that takes place on cutaneous wound healing. Here, using a
TGF-b/Scid double-knockout mouse to remove any exac-
erbated inflammatory phase found in TGF-b1-only knockout
mice, a substantial delay in each of the major phases of
wound healing was found. This included a delayed and re-
duced onset of apoptosis localized in the granulation tissue,
normally found occurring just beneath the advancing edge
of migrating epithelium (Crowe et al, 2000). It is possible
therefore that perturbation of the TGF-b system or its re-
lated co-factors by prolonging or overexpressing tTgase
during the contraction phase of wound healing may deter-
mine whether apoptosis will take place. Furthermore, irre-
spective of any putative effects on apoptosis, the potential
involvement of tTgase in activation of such an important
profibrotic protein as TGF-b combined with the overex-
pression of this enzyme by HTS has obvious implications for
the pathology of this disease.
Finally, a number of ECM proteins are known to be bound
and cross-linked by tTgase; among those molecules with
the highest binding affinity is fibronectin (Gaudry et al, 1999;
Akimov et al, 2000), a molecule known to give survival sig-
nals to cells via integrin interactions. In recent years, Grif-
fin’s group has found that fibronectin-bound tTgase
supports cell adhesion in its own capacity and in an inte-
grin-independent manner, which inhibits anoikis (Verderio
et al, 2003). They reported that cells bound to the fibronec-
tin/tTgase complex did not undergo anoikis when treated
with the small soluble RGD-containing peptides that cause
anoikis of cells bound to fibronectin. The role of fibronectin
in tTgase-related protection of HTS cells against CrIA is
currently under investigation.
The matter of exactly how tTgase is involved in the
pathogenesis of pathological scarring is still unresolved but
clearly merits further study. Our results do suggest that the
continued development of inhibitors of tTgase as therapeu-
tic anti-scarring agents may be a worthy endeavor and that
the application of these might be particularly effective as a
prophylactic measure in the weeks following successful
wound closure. The exact mechanisms via which apoptosis
is induced in these gels also remains uncertain, whether
they be through changes in mechanical forces, interactions
of cell receptors with ECM molecules, interactions of ECM
with other effectors of cellular behavior, or via ECM remod-
elling. What is clear is that this failing of pathological cells in
this particular respect not only has clinical and therapeutic
implications but also may be a useful tool by which to un-
ravel the exact mechanics of apoptosis induction under
normal wound healing circumstances.
Methods
Cell culture Fibroblast cultures were initiated from explants of re-
dundant scar tissue from a variety of body sites left over from
elective surgical procedures. All patients gave informed consent;
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the study has been approved by the West Herts Hospitals Trust
Ethics Committee and has been conducted according to the Dec-
laration of Helsinki principles. Cultures were initiated from eight NS
(3:5 ratio of male to female; mean age 26.5 y, range 8–85; scar
maturity46 mo) and six HTS–(4:2 ratio of male to female; mean
age 18.3 y, range 6–51; scar maturity46 mo). Cells were main-
tained in Dulbecco’s modified Eagles medium (DMEM) supple-
mented with 10% fetal calf serum (FCS), L-glutamine, penicillin/
streptamycin. Cultures were initiated in the following manner: the
central area of obvious scar tissue was dissected for culture in-
itiation to avoid contaminating cultures with surrounding normal
stroma. The selected tissue was finely minced with iris scissors
and placed onto the culture flask surface. Normal growth medium
was then gently added. Fibroblasts were seen to rapidly grow out
from the tissue and cover the plastic surface area; these adherent
cells were harvested by trypsinization and passaged. Cells of up to
passage number 6 were used for experimentation.
3D-collagen gels Collagen was prepared from rat tail tendons
by a modification of the extraction method of Bornstein (1958).
Hydrated collagen gels were prepared by buffering the acidic col-
lagen solution by adding 2% (vol/vol) of 11% NaHCO3 and 1.4%
1 M N-2-hydroxyethylpiperazine-N-2-ethane-sulfonic acid (pH 8)
on ice and neutralizing the pH by adding 1 M NaOH dropwise. This
mixture was further supplemented with 10  minimal essential
medium (Gibco Invitrogen, Ltd., Paisley, UK), and finally, cells were
added to give a concentration of 2  105 cells per mL. This cell-
containing collagenous mixture was then plated into six-well plates
(1.5 mL per well) and allowed to set at 371C over several hours. A
minimal growth medium (DMEM containing 1% FCS) was then
added to the gels and they were cultured for 3 d before further
experimentation. After this time, the media were refreshed and the
‘‘contractile’’ gels were freed from the plastic surface using the
blunt end of a scalpel and allowed to float freely in the medium. The
‘‘anchored’’ gels were maintained attached to the plastic surface.
Both gel types were further cultured for 4 d when they were har-
vested for photography and further analysis.
Gel solubilization and cell recovery Collagen gels were washed
twice in phosphate-buffered saline (PBS) and the gel was solubilized
by incubation at 371C with 1 mL per gel collagenase D (0.5 mg per
mL; Roche Diagnostics, Ltd, Lewes, UK) in PBS containing 5 mg per
mL bovine serum albumin. After approximately 30–40 min, when all
the gel had solubilized the released cells were harvested by cen-
trifugation and standard viability staining (trypan blue) was per-
formed or cells were air-dried onto glass slides for further analysis.
Terminal deoxynucleotidyl transferase-mediated dUTP nick
end-labelling of apoptotic cells Identification of apoptotic cells
was achieved using an adapted protocol of the APO-BRDU kit (BD
Pharmingen, San Diego, California). Briefly, cell suspensions on
glass slides were fixed for 10 min in ice-cold methanol and air-
dried. DNA-labelling solution (made up as directed by kit; contain-
ing Br-dUTP, TdT enzyme and reaction buffer) was added to the
slides and incubated for 1 h at 371C. The slides were then washed
twice with rinse buffer (kit component) and a diluted antibody so-
lution of fluorescein-labelled anti-BrdU-added and incubated in the
dark for 30 min at room temperature (RT). Finally, a propidium
iodide/Rnase solution (kit component) was added to the slide and
incubated for a further 30 min in the dark at RT. Slides were then
mounted in an anti-fade mountant and visualized using fluores-
cence microscopy.
Chemical induction of apoptosis Attempts were made to induce
apoptosis of the cells using a variety of alternative methods. Et-
hanol toxicity was used to induce apoptosis by placing the cells
into 10% (vol/vol) ethanol in SFM. Cells were observed micro-
scopically over an 8 h period for signs of toxicity (rounding up and
detaching from surface), and viable cell counts were performed.
Two cytotoxic drugs were also used to induce apoptosis: do-
xorubicin and camptothecin. Both were used over a range of con-
centration levels (not shown—optimum apoptosis was achieved
at 1 mg per mL), and the cell death was quantified over a 2-d time
course. Any death seen was confirmed as occurring via apoptosis
using nick end-labelling.
Extraction and puriﬁcation of cell-conditioned collagen An-
chored collagen gels were set up containing either NS cells or HTS
cells and cultured over the same time course used for the
apoptosis assays. Gels were harvested at days 3 and 7 for col-
lagen extraction or digestion. Extraction of the acid-soluble and -
insoluble components was performed as follows: gels were loos-
ened and washed twice (with inversion for 10 min each) with a
10  volume of PBS containing 0.1 M ethylenediaminetetraacetic
acid (EDTA) and 10 mM phenyl–methylsulfonyl fluoride. Four like
gels were pooled for each cell type and drained of wash buffer.
Three milliliters of 0.5 M acetic acid was then added and the gels
were left at 41C for 3 d to extract the acid-soluble collagen. The
samples were then centrifuged at 14,000  g (30 min at 41C) and
separated into acid-soluble (the supernatant) and acid-insoluble
(the pellet) portions. These were stored frozen until further use.
Alternatively, for direct digestion with a collagenase preparation
that had high collagenase but low tryptic activity, two like gels were
washed twice with PBS containing calcium and magnesium, and
then placed in 0.5 mg per mL collagenase D in PBS (þMgþCa)
and incubated at 371C for 40 min (10 min over that required to
completely digest the gel—as judged visually). The digested gel
solution was immediately centrifuged (4000  g for 5 min) to re-
move cellular debris and stored frozen until protein analysis by
SDS-PAGE.
Collagen digestion with MMP-2 Acid-soluble collagen prepara-
tions were neutralized by adding approximately 2:1 vol:vol of 1 M
Tris-HCl (pH 8.8), heat denatured at 601C for 15 min, and then 20
mL of these preps (at approximately 1 mg per mL collagen) were
digested in the presence of 1 mM CaCl2 with 10 mL of pre-activated
MMP-2 (100 mU per mL—R&D Systems Abingdon, UK) at 371C for
24 h. The digested collagen was analyzed using SDS-PAGE.
Immunohistochemistry All tissue samples were processed rou-
tinely, embedded in wax, and 4 mm sections were taken for stain-
ing. Antigen retrieval was performed by microwaving slides in
10 mM Tris EDTA (pH 9.0) buffer at full power (800 W) for 15 min,
and incubating for a further 15 min in the hot buffer. The slides were
then immediately washed in cold tapwater for 2–3 min and then
tTBS (2 drops Tween-20 in 500 mL of Tris-buffered saline (TBS)). All
further washes used tTBS. Four drops of streptavidin blocking so-
lution (Streptavidin Biotin Blocking Kit, Vector Labs, Burlingame,
California) were added to 1 mL each of normal horse serum block-
ing reagent (Vector Labs). This was then diluted 1:5 in Chemmate
antibody diluent (DakoCytomation, Ltd., Ely, UK) and 100 mL was
applied to each slide and incubated at RT for 30 min. This was then
replaced with primary antibody, anti-transglutaminase antibody
(Transglutaminase II Ab-3, Neomarkers, Lab Vision, California) di-
luted 1:200 in chemmate diluent containing four drops of biotin
block (Vector kit) per mL of antibody mix. The slides were then
incubated either for 1 h at RT or overnight at 41C. After washing
thoroughly with tTBS, the slides were further incubated for 30 min
at RT with a 1:100 dilution of biotinylated horse anti-mouse anti-
body (Vector Labs) followed by an incubation with a 1:200 dilution
of streptavidin alkaline phosphatase (Vector Labs). Antibody bind-
ing was visualized using the Vector phosphatase substrate kit
(Red), made up as per kit instructions plus one drop of levamisole
block for endogenous alkaline phosphatase activity (Vector Labs)
per 5 mL of substrate solution. Slides were counterstained with
Harris’s hematoxylin, dehydrated, cleared, and mounted.
Electrophoresis Collagenase D-digested fractions were subject-
ed to SDS-PAGE on 10% or 12% gels and under non-reducing
conditions. MMP-2-digested collagen was subjected to SDS-
PAGE on 7.5% gels under non-reducing conditions. Total protein
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was visualized using Coomassie Brilliant Blue R250 followed by Sil-
ver staining (ProteoSilver2 Silver stain kit—Sigma, Gillingham, UK).
Colorimetric analysis of cell number A colorimetric assay of cell
number was used that is based on cellular uptake and staining with
crystal violet dye. Briefly, 96-well plates were seeded with cells in
minimal medium and the cells were allowed to attach overnight. The
following day, the media were changed to the test media (a range of
seven different concentrations for each active in triplicate along with
a triplicate set of minimal media alone for each active tested) and the
media were refreshed twice weekly as necessary. A ‘‘time zero’’ set
of triplicates was harvested for assay at this time point to give a
starting point reading by which to judge later ones. Replica plates
were set up in this way for each time point (4, 7, and 11 d). At each
time point, the cells were fixed and stained (0.5% crystal violet, 5%
formal saline, 50% ethanol, 0.85% NaCl) for 10 min at RT and
washed 3  with PBS. The dye was then eluted using solvent (33%
acetic acid) and the optical density (OD) was read at 540 nm using a
plate-reading spectrophotometer. The OD was corrected for back-
ground, and the data were then plotted as a titration curve.
Manipulation of tissue transglutaminase activity in 3D-colla-
gen gels Inhibition of endogenous tissue transglutaminase activity
was achieved by adding various amounts of the polyamine, put-
rescine or 1,4-DAB (provided by Procyon Biopharma Inc., Dorval,
Canada), to the culture medium. 1,4-DAB is a naturally occurring
polyamine that binds to the acyl-enzyme intermediate and spe-
cifically inhibits the intended protein substrate from cross-linking,
forming an amine adduct instead. Transglutaminase activity was
increased in gels by adding exogenous tissue transglutaminase
(Sigma) to the culture medium.
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